GSTM1和GSTT1基因多态性与抗结核药物性肝损害的关系

被引:23
作者
朱冬林 [1 ,2 ]
席云 [1 ]
吴雪琼 [2 ]
机构
[1] 中山大学附属第三医院检验科
[2] 解放军第医院全军结核病研究所
关键词
GSTM1; GSTT1; 结核; 肝损害; 基因多态性;
D O I
10.13461/j.cnki.cja.004910
中图分类号
R595.3 [药源性疾病];
学科分类号
100201 [内科学];
摘要
目的探讨汉族人群谷胱甘肽S转移酶M1(GSTM1)和T1(GSTT1)基因多态性与抗结核药物性肝损害(ATDLI)易感性的关系。方法回顾性分析抗结核治疗后发生肝损害的结核病患者228例(病例组)及未发生肝损害的结核病患者300例(对照组),应用多重PCR技术检测其GSTM1和GSTT1基因多态性。结果病例组与对照组GSTM1基因缺失型频率分别为58.3%和50.7%,差异无统计学意义(OR=1.363,95%CI=0.963~1.929);GSTT1基因缺失型频率分别为45.2%和49.3%,差异也无统计学意义。联合分析也未发现两种基因在抗结核药物性肝损害发生中具有协同作用。结论汉族人群GSTM1和GSTT1基因多态性与抗结核药物性肝损害的发生无关。
引用
收藏
页码:864 / 868
页数:5
相关论文
共 8 条
[1]
利福平异烟肼合用致小鼠肝毒性增加的机理研究 [J].
薛洪源 ;
侯艳宁 ;
刘会臣 ;
冯铁静 ;
陈静 .
解放军药学学报, 2002, (06) :330-333
[2]
抗结核药物的研究进展 [J].
何国钧 ;
肖和平 .
中华结核和呼吸杂志, 2000, (10)
[3]
GSTT1 and GSTM1 gene deletions are not associated with hepatotoxicity caused by antitubercular drugs [J].
Chatterjee, S. ;
Lyle, N. ;
Mandal, A. ;
Kundu, S. .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2010, 35 (04) :465-470
[4]
Pharmacogenomics of anti-TB drugs-related hepatotoxicity [J].
Das Roy, Puspita ;
Majumder, Mousumi ;
Roy, Bidyut .
PHARMACOGENOMICS, 2008, 9 (03) :311-321
[5]
Genetic polymorphisms of manganese superoxide dismutase, NAD(P)H:quinone oxidoreductase, glutathione S-transferase M1 and T1, and the susceptibility to drug-induced liver injury [J].
Huang, Yi-Shin ;
Su, Wei-Juin ;
Huang, Yi-Hsiang ;
Chen, Chih-Yen ;
Chang, Full-Young ;
Lin, Han-Chieh ;
Lee, Shou-Dong .
JOURNAL OF HEPATOLOGY, 2007, 47 (01) :128-134
[6]
Adverse reactions to first-line antituberculosis drugs.[J].Forget;Menzies.Expert Opinion on Drug Safety.2006, 2
[7]
Reactive metabolites and their role in drug reactions [J].
Naisbitt, Dean J. ;
Williams, Dominic P. ;
Pirmohamed, Munir ;
Kitteringham, Neil R. ;
Park, B. Kevin .
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 1 (04) :317-325
[8]
Glutathione S-transferase: genetics and role in toxicology.[J].Richard C Strange;Peter W Jones;Anthony A Fryer.Toxicology Letters.2000,